Department of Infectious Diseases, Peking University Third Hospital, Beijing, China.
Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China.
Front Public Health. 2022 May 6;10:819062. doi: 10.3389/fpubh.2022.819062. eCollection 2022.
More than 200 countries are experiencing the coronavirus disease (COVID-19) pandemic. COVID-19 vaccination strategies have been implemented worldwide, and repeat COVID-19 outbreaks have been seen. The purpose of this study was to investigate the impact of COVID-19 vaccination on the reduction of perceived anxiety and the association between public anxiety and antibody testing intention during the COVID-19 pandemic.
Chinese adults aged 18 and over were surveyed using an anonymous online questionnaire in April and May 2021. The questionnaire collected sociodemographic characteristics, vaccination characteristics, perceived anxiety due to COVID-19, and attitudes toward future antibody testing after COVID-19 vaccination. Perceived anxiety was assessed on a visual analog scale (VAS). Multivariate logistic regression analysis was used to determine the factors influencing future antibody detection.
A total of 3,233 people were investigated, 3,209 valid questionnaires were collected, and the response rate was 99.3%. Of the 3,209 respondents, 2,047 were vaccinated, and 1,162 were unvaccinated. There was a significant difference in anxiety levels between vaccinated and unvaccinated respondents (24.9±25.4 vs. 50.0±33.1, respectively). With the local spread of COVID-19 in mainland China, the public anxiety VAS scores increased by 15.4±25.6 (SMD=120%) and 33.8±31.7 (SMD=49%) among vaccinated and unvaccinated respondents, respectively. Of the 2,047 respondents who were vaccinated, 1,626 (79.4%) thought they would accept antibody testing. Those who displayed more anxiety about acquiring COVID-19 disease were more likely to accept COVID-19 antibody testing. If the antibody test results showed protective antibodies, 1,190 (58.1%) were more likely to arrange travel plans in China, while 526 (25.7%) thought they would feel safer traveling abroad.
COVID-19 vaccination strategies help reduce public anxiety. However, public anxiety may be elevated as the local transmission of COVID-19 occurs in mainland China, which is usually caused now by imported cases. Those who display more anxiety choose to have antibody testing. Improving the accessibility of COVID-19 antibody tests can help ease public anxiety and enhance the confidence of some people to participate in social activities.
超过 200 个国家正在经历冠状病毒病(COVID-19)大流行。全球范围内已经实施了 COVID-19 疫苗接种策略,并出现了重复的 COVID-19 爆发。本研究的目的是探讨 COVID-19 疫苗接种对减轻感知焦虑的影响,以及公众焦虑与 COVID-19 疫苗接种后抗体检测意愿之间的关联。
2021 年 4 月至 5 月,使用匿名在线问卷对中国 18 岁及以上的成年人进行了调查。问卷收集了社会人口统计学特征、疫苗接种特征、COVID-19 引起的感知焦虑以及 COVID-19 疫苗接种后对未来抗体检测的态度。感知焦虑采用视觉模拟量表(VAS)进行评估。采用多变量逻辑回归分析确定影响未来抗体检测的因素。
共调查了 3233 人,回收了 3209 份有效问卷,应答率为 99.3%。在 3209 名应答者中,有 2047 人接种了疫苗,1162 人未接种疫苗。接种组和未接种组的焦虑水平存在显著差异(分别为 24.9±25.4 和 50.0±33.1)。随着中国大陆 COVID-19 的局部传播,接种组和未接种组的公众焦虑 VAS 评分分别增加了 15.4±25.6(SMD=120%)和 33.8±31.7(SMD=49%)。在接种疫苗的 2047 名应答者中,有 1626 名(79.4%)认为他们会接受抗体检测。那些对感染 COVID-19 疾病感到更焦虑的人更有可能接受 COVID-19 抗体检测。如果抗体检测结果显示有保护性抗体,有 1190 名(58.1%)更有可能在中国安排旅行计划,而有 526 名(25.7%)认为出国旅行会更安全。
COVID-19 疫苗接种策略有助于减轻公众焦虑。然而,随着中国大陆发生 COVID-19 的本地传播,公众焦虑可能会升高,而这通常是由输入性病例引起的。那些感到更焦虑的人选择进行抗体检测。提高 COVID-19 抗体检测的可及性有助于缓解公众焦虑,并增强一些人参与社会活动的信心。